The American Journal of Geriatric Psychiatry · Jul 27, 2025

Association Between Serum Methylmalonic Acid and Poor Cognitive Performance

By Wang Z, Deng Y, Chen L et al.

OBJECTIVE: Methylmalonic acid (MMA) accumulation, as a novel link between aging and cancer progression, had attracted widespread attention. However, there was limited evidence focusing on its association with age-related cognitive decline in elderly people. Further evidence for this will help provide new perspective on preventing cognitive disorders such as dementia. METHODS: Overall, 2,760 older adults (mean age: 69.46 years, female: 50.98%) from the National Health and Nutrition Examination Survey were included. Serum MMA concentrations were measured by gas chromatography/mass spectrophotometry. Four cognitive domains (immediate memory, delayed memory, language function, attention) were evaluated through a battery of neuropsychological tests. The global cognition was assessed by a composite z score. And the subjective cognitive decline was examined via self-reports. The weighted linear regression and logistic regression model were performed to evaluate the relationship of MMA with cognition. RESULTS: Individuals with higher MMA levels tended to have poorer cognitive function, especially in the language function and attention domain. In the logistic regression model, compared to participants with MMA <170 nmol/L, those with MMA ≥250 nmol/L have the ORs (95% confidence interval) of 1.53 (1.15, 2.04) for poor global cognition, 1.56 (1.09, 2.23) for language function, and 1.48 (1.02, 2.15) for attention. In the multivariable linear regression model, the β coefficients (95% confidence intervals) of MMA were -1.84 (-3.44, -0.25) for global cognitive score and -2.06 (-3.38, -0.74) for attention. CONCLUSION: The circulating MMA was inversely associated with global cognition, language function, and attention in older adults. The underlying causality and biological mechanisms warrant further exploration.

doi.org/10.1016/j.jagp.2025.07.006PubMed 40841220Biomarkers

AgingResearch.News